44 completed, 4 recruiting, 2 unknown, 1 terminated. 16 Phase 2, 12 Phase 3, 4 Not applicable, 3 Phase 1, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Completed 14, Terminated 1, Unknown 1 |
| Phase 3 | 12 | Completed 8, Recruiting 4 |
| Not applicable | 4 | Completed 4 |
| Phase 1 | 3 | Completed 3 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Rhinoconjunctivitis: new trials by email Literature Review of Rhinoconjunctivitis trials Research Report on Rhinoconjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df Allergen Immunotherapy Extract - Rhinitis, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 736 | 2025-04-02 | 2026-01-16 |
| Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte Clustoid® Max Forte - Mite Allergy, Dermatophagoides Farinae Allergy | Completed | Inmunotek S.L. | 140 | 2025-03-31 | 2026-02-23 | |
| Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. Specific immunotherapy (SIT) treatment, Dietary Supplement: ABB C1, Mini-tablets with pork extract - Rhinitis, Allergic Rhinoconjunctivitis | Phase 4 | Completed | Gala Servicios Clinicos S.L. | 60 | 2024-05-29 | 2025-08-29 |
| Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study Polvac Grass+Rye - Hypersensitivity, Hay Fever | Early Phase 1 | Completed | University of Zurich | 28 | 2023-11-23 | 2025-05-21 |
| Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen PQ Grass, Placebo - Seasonal Allergic Rhinitis, Rhinoconjunctivitis | Phase 3 | Completed | Allergy Therapeutics | 555 | 2022-10-11 | 2025-04-02 |
| A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment Motivation-enhancing intervention, Standard intervention - Grass Pollen Allergy, Rhinoconjunctivitis | Not applicable | Completed | University of Aarhus | 224 | 2022-09-26 | 2025-06-18 |
| Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen 10,000 MG01 + 10,000 T517, 30,000 MG01 + 10,000 T517, Placebo - Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 180 | 2021-06-14 | 2025-05-07 |
| Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. 10,000 MG01 +10,000 T521, 30,000 MG01 +10,000 T521, Placebo subcutaneous - Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 180 | 2021-05-31 | 2025-05-13 |
| Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites 10,000 MM09, 30,000 MM09, Placebo subcutaneous - Rhinitis, Allergic, Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 150 | 2020-10-06 | 2025-05-13 |
| Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber Exposure to placebo, Exposure to allergen - Allergic Rhinitis, Allergy to Pollen | Not applicable | Completed | Alyatec | 30 | 2020-02-24 | 2021-06-09 |
| Intervention in Chronic Pediatric Patients and Their Families. Ten Vida (10Vida) - Type 1 Diabetes, Allergic Rhinitis | Not applicable | Completed | University of Valencia | 500 | 2019-02-04 | 2024-03-20 |
| Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma Allergen Immunotherapy (AIT) - Rhinitis, Allergic, Rhinoconjunctivitis | Completed | Roxall Medicina España S.A | 122 | 2018-08-30 | 2021-10-20 | |
| Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects Allergen Exposure - Allergic Rhinitis, Rhinoconjunctivitis | Not applicable | Completed | Red Maple Trials Inc. | 6 | 2018-02-06 | 2018-08-24 |
| Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice Allergovac Poliplus - Allergic Rhinitis, Rhinoconjunctivitis | Completed | Roxall Medicina España S.A | 152 | 2016-11-23 | 2019-01-25 | |
| Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy MM09 Mannosylated 5.000 subcutaneous, MM09 Mannosylated 10.000 subcutaneous, MM09 Mannosylated 30.000 subcutaneous - Rhinitis, Rhinoconjunctivitis | Phase 2 | Unknown | Inmunotek S.L. | 186 | 2016-06-21 | 2020-03-11 |
| Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy MG56 Mannosylated 500 subcutaneous, MG56 Mannosylated 1000 subcutaneous, MG56 Mannosylated 3000 subcutaneous - Rhinitis, Rhinoconjunctivitis | Phase 2 | Completed | Inmunotek S.L. | 180 | 2015-12-30 | 2022-01-27 |
| A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea Allergovac depot with Olea europaea pollen extract - Rhinoconjunctivitis | Phase 1 | Completed | Roxall Medicina España S.A | 47 | 2015-09-01 | 2017-10-23 |
| A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica Allergovac depot with Parietaria judaica pollen extract - Rhinoconjunctivitis | Phase 1 | Completed | Roxall Medicina España S.A | 51 | 2015-05-01 | 2017-05-01 |
| Ragweed-SPIRE Follow-On Study Rhinoconjunctivitis, Ragweed Allergy | Completed | Circassia Limited | 249 | 2015-04-01 | 2016-03-23 | |
| Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma DP/MG/14-1, DP/MG/14-2 - Rhinitis, Rhinoconjunctivitis | Phase 2 | Completed | Laboratorios Leti, S.L. | 57 | 2014-09-01 | 2018-08-08 |
Showing 20 of 51. Sign in to see all of them.
Hypersensitivity (14) · Rhinitis, Allergic (12) · Rhinitis (11) · Asthma (8) · Rhinitis, Allergic, Seasonal (4) · Conjunctivitis (3) · Dust Mite Allergy (3) · Anxiety Disorders (1) · Ciliary Motility Disorders (1) · Conjunctivitis, Allergic (1) · Cystic Fibrosis (1) · Depression (1) · Dermatitis, Atopic (1) · Diabetes Mellitus, Type 1 (1) · Dwarfism (1)
Immune System Diseases (27) · Nose Diseases (24) · Otorhinolaryngologic Diseases (24) · Respiratory Tract Diseases (24) · Hypersensitivity, Immediate (18) · Respiratory Hypersensitivity (17) · Hypersensitivity (13) · Rhinitis (13) · Infections (12) · Respiratory Tract Infections (11) · Bronchial Diseases (8) · Lung Diseases, Obstructive (8) · Lung Diseases (7) · Conjunctival Diseases (4) · Eye Diseases (4)
Albuterol (2) · Desensitization, Immunologic (2) · Fluticasone (2) · Loratadine (2) · Mometasone Furoate (2) · Olopatadine Hydrochloride (2) · Prednisone (2) · CYT003-QbG10 (1) · Environmental Exposure (1) · Immunotherapy (1) · Parietaria judaica pollen (1) · Pork Meat (1) · Propolis (1) · Sodium (1) · Therapeutics (1)
Circassia Limited (16) · Inmunotek S.L. (7) · Allergopharma GmbH & Co. KG (4) · Laboratorios Leti, S.L. (4) · Roxall Medicina España S.A (4) · ALK-Abelló A/S (3) · University of Zurich (2) · Allergy Therapeutics (1) · Alyatec (1) · Anergis (1) · Charite University, Berlin, Germany (1) · Cytos Biotechnology AG (1) · Faes Farma, S.A. (1) · Gala Servicios Clinicos S.L. (1) · Red Maple Trials Inc. (1)
Spain (18) · Canada (14) · Germany (9) · United States (5) · Poland (4) · France (3) · Switzerland (3) · Argentina (2) · Czechia (2) · Denmark (2) · Hungary (2) · Latvia (2) · Lithuania (2) · Austria (1) · Belgium (1)
Peter Couroux, MD (3) · Deepen Patel, MD, CCFP (2) · Nicolas Hunzelmann, Prof. Dr. (2) · Alberto Caso (1) · Alicia Alonso (1) · Amparo Conde (1) · Anne K Ellis, MD MSC FRCPC (1) · Anne Poder Petersen (1) · Antonio Moreno (1) · Antonio Nieto, PhD; MD (1) · Antonio de Mateo, PhD; MD (1) · Araitz Landeta (1) · Carmen Andreu, PhD; MD (1)
PMID 25685162, PMID 31568796, PMID 19001265, PMID 21211642, PMID 21211643, PMID 21672053, PMID 24836393, PMID 32679209, PMID 33099797, PMID 38989287, PMID 40626378
2009 (1), 2014 (1), 2015 (1), 2018 (1), 2019 (1), 2023 (1)